MiRNA Profiles in Lymphoblastoid Cell Lines of Finnish Prostate Cancer Families.

MiRNA Profiles in Lymphoblastoid Cell Lines of Finnish Prostate Cancer Families.

BACKGROUND:Heritable factors are evidently involved in prostate cancer (PrCa) carcinogenesis, but currently, genetic markers are not routinely used in screening or diagnostics of the disease. More precise information is needed for making treatment decisions to distinguish aggressive cases from indol...

Full description

Bibliographic Details
Main Authors:	Daniel Fischer, Tiina Wahlfors, Henna Mattila, Hannu Oja, Teuvo L J Tammela, Johanna Schleutker
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0127427

Similar Items

NMD and microRNA expression profiling of the <it>HPCX1 </it>locus reveal <it>MAGEC1 </it>as a candidate prostate cancer predisposition gene
by: Tammela Teuvo LJ, et al.
Published: (2011-08-01)

Assessing interactions of two loci (rs4242382 and rs10486567) in familial prostate cancer: statistical evaluation of epistasis.
by: Li-Sheng Chen, et al.
Published: (2014-01-01)

Contribution of ARLTS1 Cys148Arg (T442C) variant with prostate cancer risk and ARLTS1 function in prostate cancer cells.
by: Sanna Siltanen, et al.
Published: (2011-01-01)

Microseminoprotein-Beta Expression in Different Stages of Prostate Cancer.
by: Liisa Sjöblom, et al.
Published: (2016-01-01)

Antihypertensive drug use and prostate cancer-specific mortality in Finnish men.
by: Aino Siltari, et al.
Published: (2020-01-01)

ARLTS1 and prostate cancer risk--analysis of expression and regulation.
by: Sanna Siltanen, et al.
Published: (2013-01-01)

Prostate cancer-specific survival among warfarin users in the Finnish Randomized Study of Screening for Prostate Cancer
by: Pete T. T. Kinnunen, et al.
Published: (2017-08-01)

Non-Steroidal Anti-Inflammatory Drugs and Cancer Death in the Finnish Prostate Cancer Screening Trial.
by: Thea Veitonmäki, et al.
Published: (2016-01-01)

Long‐term health‐related quality of life among men with prostate cancer in the Finnish randomized study of screening for prostate cancer
by: Kirsi Talala, et al.
Published: (2020-08-01)

Screening of Finnish <it>RAD51C</it> founder mutations in prostate and colorectal cancer patients
by: Pelttari Liisa M, et al.
Published: (2012-11-01)

Genetic determinants of EBV infection in lymphoblastoid cell lines
by: Czyz, W, et al.
Published: (2014)

Limitations of lymphoblastoid cell lines for functional analysis of SNPs
by: Hansi Pathak, et al.
Published: (2017-11-01)

Fibronectin Modulates the Expression of miRNAs in Prostate Cancer Cell Lines
by: Bruno Martinucci, et al.
Published: (2022-07-01)

Characterizing asparagine synthetase deficiency variants in lymphoblastoid cell lines
by: Stephen J. Staklinski, et al.
Published: (2023-03-01)

The viral and cellular microRNA targetome in lymphoblastoid cell lines.
by: Rebecca L Skalsky, et al.
Published: (2012-01-01)

Genetic and genomic stability across lymphoblastoid cell line expansions
by: Laura B. Scheinfeldt, et al.
Published: (2018-08-01)

Variability of gene expression profiles in human blood and lymphoblastoid cell lines
by: Min, J, et al.
Published: (2010)

Variability of gene expression profiles in human blood and lymphoblastoid cell lines.
by: Min, J, et al.
Published: (2010)

Lymphoblastoid Cell Lines as Models to Study Mitochondrial Function in Neurological Disorders
by: Sarah Jane Annesley, et al.
Published: (2021-04-01)

Variability of gene expression profiles in human blood and lymphoblastoid cell lines
by: Taylor Jennifer M, et al.
Published: (2010-02-01)

Characterization of the microDNA through the response to chemotherapeutics in lymphoblastoid cell lines.
by: Pamela Mehanna, et al.
Published: (2017-01-01)

The importance of LDL and cholesterol metabolism for prostate epithelial cell growth.
by: Teemu J Murtola, et al.
Published: (2012-01-01)

copy number variation analysis in familial BRCA1/2-negative Finnish breast and ovarian cancer.
by: Kirsi M Kuusisto, et al.
Published: (2013-01-01)

Where have all the GPs gone – where will they go? Study of Finnish GPs
by: Sumanen Markku, et al.
Published: (2012-12-01)

Psychological recovery and well-being of spouses of patients with prostate cancer 5 years after primary treatment in Finland: a follow-up survey
by: Arpo Aromaa, et al.
Published: (2023-04-01)

Preliminary study on miRNA in prostate cancer
by: Saimaitikari Abudoubari, et al.
Published: (2023-08-01)

Exosomal miRNAs as biomarkers for prostate cancer
by: Nina Pettersen Hessvik, et al.
Published: (2013-03-01)

Prostate cancer and inflammation: The role of miRNAs
by: Sabina Davidsson, et al.
Published: (2013-09-01)

Role of miRNA-182 and miRNA-187 as potential biomarkers in prostate cancer and its correlation with the staging of prostate cancer
by: Brusabhanu Nayak, et al.

Proteomics Analysis of Lymphoblastoid Cell Lines from Patients with Amyotrophic Lateral Sclerosis
by: Danielle Whitham, et al.
Published: (2023-02-01)

Comprehensive Cis-Regulation Analysis of Genetic Variants in Human Lymphoblastoid Cell Lines
by: Ying Wang, et al.
Published: (2019-09-01)

Synergistic Chemotherapy Drug Response Is a Genetic Trait in Lymphoblastoid Cell Lines
by: Kyle R. Roell, et al.
Published: (2019-10-01)

Different toxic effects of YTX in tumor K-562 and lymphoblastoid cell lines
by: Andrea Fernández Araújo, et al.
Published: (2015-06-01)

Comparison of mitochondrial DNA sequences from whole blood and lymphoblastoid cell lines
by: Chunyu Liu, et al.
Published: (2022-02-01)

Limitations of lymphoblastoid cell lines for establishing genetic reference datasets in the immunoglobulin loci.
by: Oscar L Rodriguez, et al.
Published: (2021-01-01)

The effect of freeze-thaw cycles on gene expression levels in lymphoblastoid cell lines.
by: Minal Çalışkan, et al.
Published: (2014-01-01)

Extreme clonality in lymphoblastoid cell lines with implications for allele specific expression analyses.
by: Vincent Plagnol, et al.
Published: (2008-08-01)

miRConnect: identifying effector genes of miRNAs and miRNA families in cancer cells.
by: Youjia Hua, et al.
Published: (2011-01-01)

Determinants of sickness absence rate among Finnish municipal employees
by: Tiina Vuorio, et al.
Published: (2019-01-01)

miRNAs as Therapeutic Tools and Biomarkers for Prostate Cancer
by: Noemi Arrighetti, et al.
Published: (2021-03-01)